Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellendes is a life science company specializing in the development and commercialization of innovative 3D cell culture systems. The company's core technology, the 3D-Life Hydrogel system, provides a highly flexible and modular platform for creating biomimetic microenvironments for cells. These synthetic hydrogels allow researchers to precisely control the chemical and mechanical properties of the cellular environment, facilitating advanced studies in cancer research, stem cell biology, and drug discovery. By offering a defined alternative to animal-derived matrices, Cellendes enables more reproducible and physiologically relevant in vitro models for academic and pharmaceutical research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellendes.